1. Home
  2. CYTK vs OSIS Comparison

CYTK vs OSIS Comparison

Compare CYTK & OSIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • OSIS
  • Stock Information
  • Founded
  • CYTK 1997
  • OSIS 1987
  • Country
  • CYTK United States
  • OSIS United States
  • Employees
  • CYTK N/A
  • OSIS N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • OSIS Industrial Machinery/Components
  • Sector
  • CYTK Health Care
  • OSIS Technology
  • Exchange
  • CYTK Nasdaq
  • OSIS Nasdaq
  • Market Cap
  • CYTK 4.6B
  • OSIS 3.9B
  • IPO Year
  • CYTK 2004
  • OSIS 1997
  • Fundamental
  • Price
  • CYTK $53.01
  • OSIS $233.55
  • Analyst Decision
  • CYTK Buy
  • OSIS Strong Buy
  • Analyst Count
  • CYTK 15
  • OSIS 6
  • Target Price
  • CYTK $75.57
  • OSIS $229.17
  • AVG Volume (30 Days)
  • CYTK 2.6M
  • OSIS 213.9K
  • Earning Date
  • CYTK 11-05-2025
  • OSIS 10-23-2025
  • Dividend Yield
  • CYTK N/A
  • OSIS N/A
  • EPS Growth
  • CYTK N/A
  • OSIS 18.02
  • EPS
  • CYTK N/A
  • OSIS 8.71
  • Revenue
  • CYTK $85,738,000.00
  • OSIS $1,713,166,000.00
  • Revenue This Year
  • CYTK $330.96
  • OSIS $6.70
  • Revenue Next Year
  • CYTK $73.41
  • OSIS $5.42
  • P/E Ratio
  • CYTK N/A
  • OSIS $26.86
  • Revenue Growth
  • CYTK 2635.74
  • OSIS 11.33
  • 52 Week Low
  • CYTK $29.31
  • OSIS $129.84
  • 52 Week High
  • CYTK $59.39
  • OSIS $241.64
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 77.96
  • OSIS 56.71
  • Support Level
  • CYTK $35.22
  • OSIS $226.08
  • Resistance Level
  • CYTK $50.22
  • OSIS $234.28
  • Average True Range (ATR)
  • CYTK 2.29
  • OSIS 7.85
  • MACD
  • CYTK 1.64
  • OSIS 0.51
  • Stochastic Oscillator
  • CYTK 94.73
  • OSIS 86.52

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.

Share on Social Networks: